User Login
Article Online

Journal of China Pharmaceutical University
Editor-in-Chief 
PENG Si-xun
Associate Editors-in-Chief 
WANG Ming-shi, WU Xiao-ming, WANG Guang-ji
Sponsored by
China Pharmaceutical University
Add
24 Tongjiaxiang, Nanjing, Jiangsu 210009, PRC
Tel
025-83271566
Fax
025-83271279
E-mail
cpuxuebao@sohu.com ; cpuxuebao@yahoo.com.cn
ISSN 1000-5048 CN 32-1157/R

Current Issue 2019 Vol. 50 No.3
Forward Pharmaceutical Sciences
MEI Liankuo, WEI Qiangqiang, ZHANG Huibin and ZHOU Jinpei
Research progress in acetyl-CoA carboxylase inhibitors
2019,50(3):253.  [摘要] [PDF(1791k)]
SHEN Xinxin, ZHANG Yihua and HUANG Zhangjian
Research advances in hydrogen sulfide donors
2019,50(3):265.  [摘要] [PDF(3924k)]
CAI Gongli, CHEN Yu, LIN Shuting, ZHU Dandan, DONG Yiwen, LI Ning and LIU Xiaoxuan
Application of dendrimer-based siRNA delivery systems
2019,50(3):274.  [摘要] [PDF(2225k)]
YUE Yali, YIN Jun, GAO Xiangdong and YAO Wenbing
Research advances of bispecific antibody drugs in tumor therapy
2019,50(3):289.  [摘要] [PDF(2320k)]
Original Articles
XIN Junbo, LI Fang, LI Ruohan, ZHANG Ran, PAN Furong and MING Xin
Eight-arm polyethylene glycol nanoconjugates for brain targeted delivery of photosensitizer
2019,50(3):299.  [摘要] [PDF(4466k)]
LIN Xia#, LI Na#, LI Jinwei, YANG Ziyi and JIN Jian
Preparation and evaluation of an oral insulin enteric preparation based on polymer-lipid hybrid nanoparticles
2019,50(3):308.  [摘要] [PDF(1247k)]
AN Jiong, LI Kan, XU Xiaoming, GAO Zhun, HU Chao, LI Bo, DI Bin and XU Lili
Development and validation of a novel and simple RP-HPLC method for the determination of related substances of tiopronin for injection
2019,50(3):317.  [摘要] [PDF(1642k)]
LUAN Baolei, XU Xinjun, LIANG Guiting, YOU Mengmeng and LIU Guozhu
Determination of related genotoxic impurities in olmesartan medoxomil by HPLC-MS
2019,50(3):325.  [摘要] [PDF(929k)]
WANG Yingxin, LIU Ling, LI Shuying, LAN Yi and NIE Lei
Analysis of related substances in montelukast sodium granules by HPLC-MS/MS
2019,50(3):330.  [摘要] [PDF(1516k)]
GU Yufeng, PAN Xiuxiu, SONG Ling, YANG Xing, HU Liang and LIU Wentao
Experimental study of metformin in relieving bone cancer pain by inhibiting JNK and improving gap junction function
2019,50(3):337.  [摘要] [PDF(4008k)]
XU Manli, WANG Chang, WANG Nan, HE Hongpeng, ZHANG Tongcun and LUO Xuegang
MALAT1 upregulates SMYD3 by competition with miR-124 and promotes proliferation and migration of breast cancer cells
2019,50(3):344.  [摘要] [PDF(2656k)]
ZHANG Fan, TIAN Hong and YAO Wenbing
Establishment of a high-throughput analysis method for the identification of key proteases of peptide drugs in vitro
2019,50(3):352.  [摘要] [PDF(920k)]
Reviews
CHENG Weihua#, GUO Feihu#, DENG Xuesong, QIN Xiangyu, FAN Hongqiang and HU Ji
Research progress of synthetic methods of [18F]F-DOPA
2019,50(3):357.  [摘要] [PDF(1017k)]
Monograph
ZHAO Dongmei, FANG Changjin and QIU Zhixia
Patent analysis for coagulation factor Xa inhibitors
2019,50(3):364.  [摘要] [PDF(4055k)]
SUN Chuanliang and SUN Libing
IncoPat-based patent analysis of China Pharmaceutical University
2019,50(3):374.  [摘要] [PDF(1344k)]

Copyright Editorial Office of Journal of China Pharmaceutical University  苏ICP备11026256号
Address:24 Tongjiaxiang, Nanjing, Jiangsu Province, PRC TEL: 025-83271566 83271562 FAX: 025-83271279 E-mail:cpuxuebao@sohu.com; cpuxuebao@yahoo.com.cn
Technical Support: Beijing Qin-Yun Technology Development Co., Ltd.